GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Leonteq AG (XSWX:LEON) » Definitions » 12-1 Month Momentum %

Leonteq AG (XSWX:LEON) 12-1 Month Momentum % : -29.64% (As of Dec. 12, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Leonteq AG 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-12), Leonteq AG's 12-1 Month Momentum % is -29.64%.

The industry rank for Leonteq AG's 12-1 Month Momentum % or its related term are showing as below:

XSWX:LEON's 12-1 Month Momentum % is ranked worse than
90.87% of 1720 companies
in the Asset Management industry
Industry Median: 8.235 vs XSWX:LEON: -29.64

Competitive Comparison of Leonteq AG's 12-1 Month Momentum %

For the Asset Management subindustry, Leonteq AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leonteq AG's 12-1 Month Momentum % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Leonteq AG's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Leonteq AG's 12-1 Month Momentum % falls into.



Leonteq AG  (XSWX:LEON) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Leonteq AG  (XSWX:LEON) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Leonteq AG 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Leonteq AG's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Leonteq AG Business Description

Traded in Other Exchanges
Address
Europaallee 39, Zurich, CHE, 8004
Leonteq AG is a Swiss fintech company with a marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has a presence in its home market of Switzerland and Europe, as well as an established footprint in Asia and other countries.

Leonteq AG Headlines

From GuruFocus

Leone Asset Management Signs Joint Venture

By ACCESSWIRE ACCESSWIRE 04-20-2023

Leone Asset Management Releases Q1 Update

By ACCESSWIRE ACCESSWIRE 04-11-2023

Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired 03-29-2018

UPDATE:  Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired 03-29-2018